Okkeun Jung, Angelene Soto, Andrew L. Wolfe, Shahana S. Mahajan. "Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity." PLoS ONE (2025). https://doi.org/10.1371/journal.pone.0329946